STRS Ohio’s Forte Biosciences FBRX Stock Holding History

STRS Ohio’s Portfolio FBRX Stock Details FBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,076	Closed	-$39K	–	2120
2022 Q1	$39K	Hold	1,076	–	–	﹤0.01%	1975
2021 Q4	$57K	Buy	1,076 +972	+935%	+$65.4K	﹤0.01%	1984
2021 Q3	$7K	Hold	104	–	–	﹤0.01%	2210
2021 Q2	$87K	Buy	+104	New	+$93.7K	﹤0.01%	2003
2018 Q1	–	Sell	-7	Closed	-$25K	–	1887
2017 Q4	$25K	Hold	7	–	–	﹤0.01%	1807
2017 Q3	$31K	Hold	7	–	–	﹤0.01%	1844
2017 Q2	$30K	Buy	+7	New	+$39.4K	﹤0.01%	1855

Other funds holding FBRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

STRS Ohio's FBRX Position: Q2 2022 in Review

STRS Ohio sold out of Forte Biosciences (FBRX) in Q2 2022, closing a stake of 1,076 shares — an estimated $39K sold.

STRS Ohio first reported a position in FBRX in Q2 2017 and held it in 7 quarters. The position peaked at $87K in Q2 2021. 39 funds tracked by Wall St. Rank hold FBRX as of Q2 2022.

STRS Ohio reported no remaining Forte Biosciences position as of Q2 2022 after selling out during the quarter.
STRS Ohio sold 1,076 Forte Biosciences shares in Q2 2022, an estimated $39K.
STRS Ohio first reported a position in Forte Biosciences in Q2 2017 and held it in 7 quarters.
STRS Ohio's Forte Biosciences position peaked at $87K in Q2 2021.
39 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2022.

Based on STRS Ohio's 13F filing for Q2 2022, filed 25 Jul 2022.